Your browser doesn't support javascript.
loading
Proteomic examination of the neuroglial secretome: lessons for the clinic.
Kim, Jong-Heon; Afridi, Ruqayya; Lee, Won-Ha; Suk, Kyoungho.
Affiliation
  • Kim JH; Brain Science & Engineering Institute, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
  • Afridi R; Department of Pharmacology, Brain Science & Engineering Institute, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Lee WH; School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea.
  • Suk K; Brain Science & Engineering Institute, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
Expert Rev Proteomics ; 17(3): 207-220, 2020 03.
Article in En | MEDLINE | ID: mdl-32187501
ABSTRACT

Introduction:

Glial cells are closely associated with neurons located throughout the nervous system and regulate neuronal activity and function through various mechanisms including the secretion of proteins and other signaling molecules. Glia-secreted proteins play crucial roles in modulating neuronal function in physiological and pathological conditions. Aberrant activation of glial cells leading to neuroinflammation is a common phenomenon observed in various neurological disorders. Aberrantly activated glial cells secrete proteins in disease-specific manner and can be exploited as a repository for novel biomarker discovery.Areas covered In this review, we describe the recent advances in proteomic techniques, highlighting the need for their application to the secretomic field. Studies regarding the secretome profile of glial cells published within the last 5 years are discussed in detail. The use of glia-based biomarkers in various neuroinflammatory and neurodegenerative diseases is also discussed.Expert opinion Precise diagnosis and timely treatment of neurological disorders remains a challenge and glia-focused research to identify specific biomarkers appears to be a promising approach to combat these disorders. Recent technological advancement in proteomic research would open new frontiers for more rigorous analysis of glial secretome variations over time and the discovery/development of novel biomarkers for neurological disorders.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Neuroglia / Neurodegenerative Diseases / Proteomics / Neurons Limits: Humans Language: En Journal: Expert Rev Proteomics Journal subject: BIOQUIMICA Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Neuroglia / Neurodegenerative Diseases / Proteomics / Neurons Limits: Humans Language: En Journal: Expert Rev Proteomics Journal subject: BIOQUIMICA Year: 2020 Type: Article